CMV and HSV Pneumonia After Immunosuppressive Agents for Treatment of Cytokine Release Syndrome Due to Chimeric Antigen Receptor–modified T (CAR-T)-Cell Immunotherapy. Issue 9 (9th November 2021)

• Record Type: Journal Article
• Authors: Heldman, Madeleine R.; Ma, Jimmy; Gauthier, Jordan; O'Hara, Riley A.; Cowan, Andrew J.; Yoke, Leah M.; So, Lisa; Gulleen, Elizabeth; Duke, Elizabeth R.; Liu, Catherine; Turtle, Cameron J.; Hill, Joshua A.
• Is Part Of: Journal of immunotherapy. Volume 44:Issue 9(2021)
• Page Start: 351
• Page End: 354
• Publication Date: 2021-11-09
• Subjects: cytomegalovirus (CMV) -- herpes simplex virus-1 (HSV-1) -- chimeric antigen receptor–modified T (CAR-T)-cell therapy -- immunotherapy -- pneumonia; Immunotherapy -- Periodicals; Immunotherapy -- Periodicals; Neoplasms -- therapy -- Periodicals; Electronic journals; Electronic journals; 615.37
• DOI: 10.1097/CJI.0000000000000388
• Languages: English
• ISSNs: 1524-9557

Abstract

Abstract : Pneumonia due to cytomegalovirus and herpes simplex virus-1 caused substantial morbidity after hematopoietic cell transplantation before the institution of preventative approaches. End-organ disease from herpesviruses is poorly described after chimeric antigen receptor–modified T-cell immunotherapy. We report 2 cases of cytomegalovirus pneumonia and 1 case of herpes simplex virus-1 gingivostomatitis, esophagitis, and pneumonia after chimeric antigen receptor–modified T-cell immunotherapy for the treatment of hematologic malignancies.